Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
There's no point holding worry with your shares and spreading that worry here.
People are posted with their own interests at heart.
If you're worried then at least inform us why, so that people can understand when reading this.
Otherwise it just comes across as a blatent deramp.
Also how on earth can he boast that it's more efficacious than SNG's product? He only just spoke about trialling the drug in Australia on 12-15 people. Even Richard, who was quietly confident a few weeks ago, refrained from making such bold claims without the data to back up his thoughts.
Have the fundamentals here changed?
It makes me laugh to see poor efforts from the derampers like Punit, who's best shot at deramping is "I'm worried.."
This forum is full of factual information from those that bother to do their research.
If you're worried, all you need to do is read the multiple informative posts here.
There's no downside to this share apart from a few people taking profit.. that'll change in a number of days at most.
The risk has now gone and after verification of these results, the drug is bound to be approved by various regulators or sent to a large scale phase 3 trial at the very least.
Even without the Covid play - COPD results are on their way.
Until the big news, this will fluctuate - I'll be sitting back and waiting for further entry points knowing I'm already fastened in for the big news.
You're not alone. Still here from 50p all in.. the legs on this one is incredible. I'm already sat on a life changing profit at these levels, but to me, the risk is gone.
It only now needs the bigger attention it deserves. The past couple of days have seen it begin to receive that, both here and in the states.
I'm no scientist, but everything you read or watch about this drug is a no brainer.
The applications for it are broad as it is generic. It's naturally occurring. It's already the most promising treatment available.
Safety proven in multiple trials. Now the efficacy is showing through on the recent phase 2.
If you're not sold already then have a watch of this already heavily posted video on Youtube.
https://www.youtube.com/watch?v=wqDd7ixh184
I think with all the best will in the world, the home trials won't be any time soon - it was expected next year if I recall.
Being realistic, the big plays on this now are buyout and the COPD trials in the very short term.
This share price is still ludicrously cheap given the now proven results of this drug.
Thanks for your post - you had me bought in here early on.
It was a rough ride, but common sense came through.
I'm no scientist, but from the posts on here it was evident that the numbers and the results were going to stack up.
Trial results from three separate trials in the next few months, all seemingly heading towards a positive outcome.
No sentiment is causing the current drop.
Stick to the fundamentals and realise why you originally invested.
Sit back and wait until June. I think any rise at the moment is likely to be countered by Lansdowne selling off their bit.
This would have naturally risen without that. The results will steer it significantly (hopefully in the right direction...!)
I mulled over this one yesterday as I had concerns about the NHS post. The effort to get candidates for the home trials does sound a bit long winded, but -
* There are no other medications being performed in this space for COVID-19. SNG001 will be at the forefront of patient treatment prior to hospitalisation, something no doubt the NHS will want to push heavily to keep hospitalised numbers down.
* There are still 4,000 COVID-19 cases being diagnosed a day. Even if candidates have to meet a specific criteria, there should be a reasonable uptake.
* They have determined the medication as safe, which is great news given what we've heard regarding other existing medications that are being trialled.
I'm eager to understand the results of the initial trials in the hospital arena. To me there are two possible takes from this -
* Trials have gone exceptionally well, shown an improvement in patients and there is now a case to see if they can prevent hospitalisation with the drug.
* Trials haven't shown much of an effect, but there is a thought that if the drug was introduced earlier, that there would be a much larger success rate.
I'm hoping it's more of the former and less of the latter. Either way if the hospitalised trials didn't show much of a result, there's obviously reason to believe that introducing the drug earlier would provide benefit.